Joint pain
Meta-analyses found fewer painful joints and an average reduction in pain.
html
EPA and DHA influence eicosanoids and inflammatory pathways involved in joint pain and stiffness. Meta-analyses of randomized trials show measurable benefits in rheumatoid arthritis and osteoarthritis.
Meta-analyses found fewer painful joints and an average reduction in pain.
In osteoarthritis, function and mobility improved in pooled analyses of RCTs.
In rheumatoid arthritis, longer studies showed a lower need for non-steroidal anti-inflammatory drugs.
Trials in rheumatoid arthritis confirmed higher EPA/DHA and a lower omega-6:3 ratio alongside clinical outcomes.
Pain and mobility should also be considered in the context of chronic low-grade inflammation. If you train, also see omega-3 and athletes; to preserve independence over the years, see longevity and older adults.
A recent meta-analysis assessed biomarkers and joint symptoms.
Supplementation increased EPA and DHA incorporation.
The fatty-acid balance shifted in a more favorable direction.
The number of painful joints decreased, with an approximate SMD of −0,59.
PMID 38922552 →Related scientific studyNine randomized trials included 2,070 people with osteoarthritis.
Average pain reduction with SMD −0,29.
Functional improvement with SMD −0,21.
The effect was observed across the included trials.
PMID 37226250 →Related scientific studyContinue from the article to reviewed presentations and return to the topic pages whenever you want to examine the evidence in more depth.